Used primarily in pharmaceutical research as an intermediate in the synthesis of active pharmaceutical ingredients (APIs), particularly in the development of central nervous system (CNS) agents. Its structure supports binding to neurological receptors, making it valuable in the design of antihistamines, antidepressants, and wake-promoting medications. The compound’s azetidine ring and diphenylmethyl group contribute to blood-brain barrier penetration and receptor affinity. It is also explored in medicinal chemistry for optimizing drug metabolism and pharmacokinetic profiles.